Human Limb Regeneration by 2030

Limb Regeneration

On Veteran’s Day the University of Connecticut announced the launch of its new grand research challenge: regeneration of a human knee within 7 years, and an entire limb within 15 years. This major international research undertaking, called The HEAL Project, stands for Hartford Engineering a Limb. It is the brainchild of UConn Health’s Cato T.…

Read More

Nanostructured sunscreen ingredient may prevent medical implant MRSA infections

sunscreen

A common ingredient in sunscreen could be an effective antibacterial coating for medical implants such as joint replacements and pacemakers. Zinc oxide nanopyramids can disrupt methicillin-resistant Staphylococcus aureus (MRSA), reducing the film of bacteria growing on coated materials by over 95 percent. About one million implanted medical devices are infected each year. “It is extremely…

Read More

Spectranetics Announces FDA Clearance of Turbo-Power(TM) Laser Atherectomy Catheter

Spectranetics

COLORADO SPRINGS, Colo., Nov. 12, 2015 (GLOBE NEWSWIRE) — The Spectranetics Corporation (SPNC) today announced receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance of its peripheral atherectomy product, the Turbo-Power(TM) Laser Atherectomy Catheter, for the treatment of in-stent restenosis (ISR). Laser atherectomy is driving a new standard of care for in-stent restenosis treatment…

Read More

Boston Scientific To Acquire Interventional Radiology Business Of CeloNova Biosciences

Boston Scientific

MARLBOROUGH, Mass., Nov. 10, 2015 /PRNewswire/ — Boston Scientific (NYSE: BSX) has entered into a definitive agreement to acquire the interventional radiology portfolio of CeloNova Biosciences, a San Antonio-based developer of endovascular and interventional cardiology technologies. The structured agreement includes drug-eluting microspheres designed to be loaded with chemotherapy drugs for delivery to cancerous tumors, and…

Read More

Measure Blood Flow Through Skin Sensor

Skin Sensor

The Rogers Research Group at the University of Illinois at Urbana-Champaign have expanded on their flexible skin sensor technology to measure blood flow in vessels 1 to 2 millimeters under the skin. Current methods to measure blood flow in a clinical setting rely on optical imaging techniques that require patients to remain still for the…

Read More

Sherwin-Williams Launches Breakthrough Paint With the Power to Kill Bacteria

Sherwin-Williams

Sherwin-Williams announces the launch of Paint Shield™, the first EPA-registered microbicidal paint that continuously kills these difficult-to-treat, infection-causing bacteria after two hours of exposure on painted surfaces. By killing these infectious bacteria on painted surfaces, Paint Shield offers customers an important new tool to help prevent the spread of bacteria that can cause hospital-acquired infections…

Read More

Smith & Nephew Shrugs Off Buyout Talk With 275M Blue Belt Technologies Acquisition

Smith & Nephew

Smith & Nephew, British-based orthopedics giant, has expanded its foothold in the surgical robotics market with the $275 million acquisition of U.S.-based Blue Belt Technologies and its Navio robotics system. By combining its next-generation products with robotic technology, Smith & Nephew hopes to expand its market share and explore new surgical indications — all under…

Read More

Medtronic Buys Lazarus Effect For 100 Million

Medtronic

Medtronic is acquiring private-held Lazarus Effect, developer of a mesh cover for stent retrievers of blood clots, for $100 million in cash. As part of the deal, Medtronic obtains the Lazarus Cover device, which will serve as an adjunct to Medtronic’s Solitaire stent retriever device, used to remove clots from acute ischemic stroke patients. A…

Read More

Risk Management: A Total Product Life-cycle Process [Infographic]

Risk Management

Risk Management is a total product life-cycle process. It’s not something you only do at the beginning or the end. As long as you produce a medical device, you must remember to plan for Risk Management. Unfortunately, risk management efforts have a tendency to trail off and be forgotten once a product is launched. Don’t…

Read More

Osiris Therapeutics Adds TruSkin™ to it’s Wound Care Portfolio

Osiris Therapeutics

COLUMBIA, Md.–(BUSINESS WIRE)–Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading cellular regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, announced today the launch of TruSkin™, a cryopreserved, living skin allograft. TruSkin has been developed to provide healthcare professionals a new option for treating large, chronic wounds…

Read More